Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Z Varga

Showing results (201-210 of 241) with videos related to

Pageof 25
Sort By:
British Journal of Cancer|November 26, 2014
Prognostic factors in metaplastic carcinoma of the breast: a multi-institutional studyE A Rakha, P H Tan, Z Varga, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 22, 2017
Adipokines as atherothrombotic risk factors in obese subjects: Associations with haemostatic markers and common carotid wall thicknessÉ Csongrádi, M Káplár, B Nagy, et al.
British Journal of Cancer|June 10, 2010
Endogenous myoglobin in human breast cancer is a hallmark of luminal cancer phenotypeG Kristiansen, M Rose, C Geisler, et al.
Scientific Reports|June 3, 2023
Towards virtual histology with X-ray grating interferometryM Polikarpov, J Vila-Comamala, Z Wang, et al.
Journal of Applied Crystallography|October 4, 2018
Model-free classification of X-ray scattering signals applied to image segmentationV Lutz-Bueno, C Arboleda, L Leu, et al.
British Journal of Cancer|August 28, 2015
Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2)J Feilchenfeldt, Z Varga, M Siano, et al.
British Journal of Cancer|December 24, 2015
Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2)J Feilchenfeldt, Z Varga, M Siano, et al.
Folia Biologica|December 19, 2003
Efficacy and safety of inhaled recombinant interleukin-2 in high-risk renal cell cancer patients compared with systemic interleukin-2: an outcome studyE Huland, A Burger, J Fleischer, et al.
Current Medicinal Chemistry|November 11, 2008
Signalling inhibitors against Mycobacterium tuberculosis--early days of a new therapeutic concept in tuberculosisB Hegymegi-Barakonyi, R Székely, Z Varga, et al.
Breast Cancer Research and Treatment|November 15, 2014
Pathological non-response to chemotherapy in a neoadjuvant setting of breast cancer: an inter-institutional studyD Balmativola, C Marchiò, M Maule, et al.
Pageof 25

Showing results (201-210 of 241) with videos related to

Sort By:
Pageof 25
British Journal of Cancer|November 26, 2014
Prognostic factors in metaplastic carcinoma of the breast: a multi-institutional studyE A Rakha, P H Tan, Z Varga, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 22, 2017
Adipokines as atherothrombotic risk factors in obese subjects: Associations with haemostatic markers and common carotid wall thicknessÉ Csongrádi, M Káplár, B Nagy, et al.
British Journal of Cancer|June 10, 2010
Endogenous myoglobin in human breast cancer is a hallmark of luminal cancer phenotypeG Kristiansen, M Rose, C Geisler, et al.
Scientific Reports|June 3, 2023
Towards virtual histology with X-ray grating interferometryM Polikarpov, J Vila-Comamala, Z Wang, et al.
Journal of Applied Crystallography|October 4, 2018
Model-free classification of X-ray scattering signals applied to image segmentationV Lutz-Bueno, C Arboleda, L Leu, et al.
British Journal of Cancer|August 28, 2015
Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2)J Feilchenfeldt, Z Varga, M Siano, et al.
British Journal of Cancer|December 24, 2015
Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2)J Feilchenfeldt, Z Varga, M Siano, et al.
Folia Biologica|December 19, 2003
Efficacy and safety of inhaled recombinant interleukin-2 in high-risk renal cell cancer patients compared with systemic interleukin-2: an outcome studyE Huland, A Burger, J Fleischer, et al.
Current Medicinal Chemistry|November 11, 2008
Signalling inhibitors against Mycobacterium tuberculosis--early days of a new therapeutic concept in tuberculosisB Hegymegi-Barakonyi, R Székely, Z Varga, et al.
Breast Cancer Research and Treatment|November 15, 2014
Pathological non-response to chemotherapy in a neoadjuvant setting of breast cancer: an inter-institutional studyD Balmativola, C Marchiò, M Maule, et al.
Pageof 25